In patients with COVID-19 with acute respiratory failure, probability of 1-year survival was 84.42% in those who used antifibrotics vs 69.87% in those who did not. The use of antifibrotic agents ...
Initial screening colonoscopy and a follow-up after abnormal stool-based test results can help with earlier CRC detection. It is necessary to implement follow-up colonoscopy after an abnormal ...
While safety is comparable in both drugs, subcutaneous infliximab is superior in efficacy to vedolizumab for treating Crohn disease. Subcutaneous infliximab is more efficacious maintenance treatment ...
Credit: Getty Images The American Society of Colon and Rectal Surgeons has released new guidelines on the diagnosis and treatment of hemorrhoids. The American Society of Colon and Rectal Surgeons ...
Decreasing sitting time by more than 30 minutes in older adults can reduce systolic blood pressure. Systolic blood pressure in older adults can be reduced by decreasing daily sitting time by more than ...
Physicians at a hematology and oncology practice in Texas have agreed to pay over $1.3 million to resolve alleged violations of the False Claims Act. The practice had entered into an unlawful kickback ...
While low fluid infusion leads to better clinical outcomes, it is also associated with higher mortality. Currently available data did not clearly support a specific fluid infusion resuscitation volume ...
Endoscopic cuffitis occurs in approximately 60% of patients with UC who undergo RPC and IPAA. Among patients with ulcerative colitis (UC) who had restorative proctocolectomy (RPC) with stapled ileal ...
Lower extremity amputation risk was lower among users of SGLT-2 inhibitors vs DPP-4 inhibitors but higher among users of SGLT-2 inhibitors vs sulfonylureas. Among patients with type 2 diabetes, sodium ...
Individuals with type 2 diabetes who have received insulin treatment may have an increased risk for advanced adenomas. Insulin therapy is associated with an increased risk for advanced colorectal ...
The risks of mobility and self-care disability were highest for patients with brain, bone, and pancreatic cancer. US cancer survivors are more likely than the general population to have a mobility or ...
Most cancer drugs that receive accelerated approval from the FDA do not confer a clinical benefit within 5 years of approval, data suggest.